Type 2 diabetes remission achievable even at lower body weights
New Insights from the ReTUNE Trial
A groundbreaking study led by Professor Roy Taylor and his team at Newcastle University suggests that people with lower...
Health benefits and side effects of diabetes drug metformin
Metformin is a medication commonly used to treat type 2 diabetes.
It works by reducing the amount of glucose produced by the liver and increasing...
The power of linoleic acid: Lowering type 2 diabetes risk and more
The Skinny on Linoleic Acid
Linoleic acid. It's a bit of a tongue twister, isn't it? But it's a name you may want to remember....
Type 2 diabetes drug may lower dementia risk, study finds
Type 2 Diabetes and Dementia
Type 2 diabetes is a chronic condition in which the body becomes resistant to insulin or doesn’t produce enough insulin,...
Turmeric and vitamin D may lower blood pressure in type 2 diabetes patients
Introduction to Curcuminoids and Vitamin D
A recent study from Urmia University of Medical Sciences found that turmeric compounds and vitamin D supplementation may improve...
Chewing food properly may improve blood sugar in people with type 2 diabetes
A study by University at Buffalo researcher Mehmet A. Eskan has suggested that healthcare providers treating people with type 2 diabetes (T2D) should check...
Potency drug can lower blood sugar in long-term in type 2 diabetes
A pilot study conducted at the University of Gothenburg found that people with type 2 diabetes who were treated with high-dose tadalafil strongly improved...
Diabetes drugs linked to reduced heart disease events in older veterans
GLP1 receptor agonists, a class of diabetes medications, may be associated with fewer major adverse heart disease events than another type of diabetes drug,...
Exercise for type 2 diabetes: What you need to know
Type 2 diabetes is a chronic condition that affects millions of people worldwide.
It is characterized by high blood sugar levels due to the body's...
Latest diabetes drug may help prevent kidney and lung diseases
Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are a relatively new class of drugs that have been developed for the treatment of type 2 diabetes.
In recent...